Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$27K Hold
102
﹤0.01% 385
2022
Q1
$24K Hold
102
﹤0.01% 431
2021
Q4
$23K Sell
102
-3,651
-97% -$776K ﹤0.01% 439
2021
Q3
$751K Buy
3,753
+126
+3% +$27.4K 0.03% 165
2021
Q2
$860K Hold
3,627
0.04% 153
2021
Q1
$877K Sell
3,627
-64
-2% -$14.3K 0.05% 146
2020
Q4
$768K Buy
3,691
+54
+1% +$10.6K 0.04% 150
2020
Q3
$616K Hold
3,637
0.04% 154
2020
Q2
$682K Hold
3,637
0.05% 138
2020
Q1
$644K Hold
3,637
0.06% 122
2019
Q4
$744K Hold
3,637
0.07% 132
2019
Q3
$552K Hold
3,637
0.05% 152
2019
Q2
$573K Hold
3,637
0.06% 149
2019
Q1
$585K Hold
3,637
0.06% 144
2018
Q4
$691K Buy
+3,637
New +$759K 0.09% 122

Other funds holding CI

RBC Europe's CI Position: Q2 2022 in Review

RBC Europe held its Cigna (CI) position steady in Q2 2022 at 102 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #385.

RBC Europe first reported a position in CI in Q4 2018 and has held it in 15 quarters since. The position peaked at $877K in Q1 2021. 1,441 funds tracked by Wall St. Rank hold CI as of Q2 2022.

  • RBC Europe held 102 shares of Cigna worth $27K as of Q2 2022.
  • RBC Europe left its Cigna share count unchanged in Q2 2022.
  • Cigna made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #385 holding.
  • RBC Europe first reported a position in Cigna in Q4 2018 and has held it in 15 quarters since.
  • RBC Europe's Cigna position peaked at $877K in Q1 2021.
  • 1,441 funds tracked by Wall St. Rank held Cigna as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.